Evotec SE EVO
NASDAQ EVO
$1.60 -0.04 (-2.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

Evotec SE (EVO) Gains from Equity Investments (2021)

Updated

Evotec SE's Gains from Equity Investments was -$36.01 million in the quarter ended Dec 31, 2021.

Analysis

Evotec SE (EVO) Gains from Equity Investments (2021) Analysis & Trends

For the year ended Dec 31, 2021, Gains from Equity Investments at Evotec SE came in at $255.03 million.

  • In earlier years, Gains from Equity Investments was $7.17 million in the year ended Dec 31, 2020 (-82.8%) and $41.79 million in the year ended Dec 31, 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.51 Bn 34.35 Bn 1.44 Bn
2 Medpace Holdings 16.73 Bn 14.79 Bn 201.64 Mn
3 Charles River Laboratories International 13.84 Bn 13.08 Bn 363.37 Mn
4 Icon 12.41 Bn 9.52 Bn 479.29 Mn
5 Fortrea Holdings 1.90 Bn 1.28 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 786.20 Mn 24.11 Mn 18.44 Mn
7 Evotec SE 568.89 Mn -1.00 Bn -
8 Champions Oncology 68.76 Mn 44.41 Mn 7.70 Mn
9 MindWalk Holdings 62.59 Mn 26.81 Mn 1.61 Mn
10 Natural Alternatives International 8.92 Mn -19.16 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -36.01 Mn
API Access

Evotec SE Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=EVO&period=max&api_key=YOUR_API_KEY